[Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
作者信息
Naito I
出版信息
Rinsho Ketsueki. 1984 Jul;25(7):1027-35.
PMID:6389929
Abstract
摘要
相似文献
1
[Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
Rinsho Ketsueki. 1984 Jul;25(7):1027-35.
2
Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):122-36.
3
[Cerebral vessels and thrombosis].
Rinsho Ketsueki. 1984 Jul;25(7):1018-26.
4
[Treatment with the urokinase-lysyl plasminogen combination of developmental outbreaks of arteriopathies].
Ann Med Interne (Paris). 1986;137(2):105-7.
5
Clinical effects and basic studies of thrombolytic therapy on cerebral thrombosis.
Semin Thromb Hemost. 1990 Jul;16(3):236-41. doi: 10.1055/s-2007-1002675.
6
Effect of oral urokinase and its clinical application.
New Istanbul Contrib Clin Sci. 1982;13(3):161-70.
7
[Thrombolytic efficacy of a Lys-plasminogen-urokinase combination: studies in experimental animals and humans].
Angiologia. 1990 Nov-Dec;42(6):218-26.
8
[Value of Lysyl-plasminogen-urokinase sequential treatment in thrombolytic therapy].
Coeur Med Interne. 1977 Oct-Dec;16(4):513-21.
9
[Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
Nihon Naika Gakkai Zasshi. 1979 May 10;68(5):486-9.
引用本文的文献
1
Thrombolysis for acute ischaemic stroke.
Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD000213. doi: 10.1002/14651858.CD000213.pub3.
Zotero 插件